Companies face different situations today when moving into a strategic approach to IP management. This white paper aims to summarize these situations and reflects the views of ~400 IP and innovation professionals working in IP and innovation (R&D, R&I or the like) departments in a wide range of companies (large and SMEs), patent law firms and other organizations. The document is a compilation of both positive and less positive experiences, i.a. on the design, the implementation and the execution of the IP plan.
Download now the whitepaper 'IP strategy'.
Editor: Patentopolis B.V.
This qualifying course is tailoured to your needs - you choose the regulatory information you need and attend the courses you like to.
This live webcast provides you regularly with the detailed presentation of the EPO's Boards of Appeal on computer-implemented inventions and their impact on your prosecution practice.
This live webcast provides you regularly with the detailed presentation of the EPO's Boards of Appeal on computer-implemented inventions and their impact on your prosecution practice.
This live webcast provides you regularly with the detailed presentation of the EPO's Boards of Appeal on computer-implemented inventions and their impact on your prosecution practice.
This live webcast provides you regularly with the detailed presentation of the EPO's Boards of Appeal on computer-implemented inventions and their impact on your prosecution practice.
This live webcast provides you regularly with the detailed presentation of the EPO's Boards of Appeal on computer-implemented inventions and their impact on your prosecution practice.
This live webcast provides you regularly with the detailed presentation of the EPO's Boards of Appeal on computer-implemented inventions and their impact on your prosecution practice.
The most important published and unpublished decisions of the EPO Boards of Appeal in the field of pharmaceuticals and chemistry will be presented.
The conference offers you once again the most recent developments in IP for the seed industry and the breeders.
The most important decisions of the Boards of Appeal in the field of biopharmaceuticals and biotechnology and changes in the Guidelines will be presented. The panelists will discuss, in particular, the consequences of these decisions and changes on patent practice.
This e-learning will familiarise you with the regulatory affairs principles outside the ICH region and show you how to categorise the various regions in terms of regulatory requirements. Dossier requirements in Australia, Hong Kong, India, South Korea, Taiwan, Saudi Arabia, GCC, Jordan, Turkey, Thailand, China, South Africa, Russia, Kazakhstan, Eqypt, Brazil, Mexico & Argentina will be addressed
